Cg Oncology Inc.
CGON
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.94B
Close$
$-3.51
105.2% downside
Current Fair Value
105.2% downsideOvervalued by 105.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.94 Billion |
|---|---|
| Enterprise Value | $5.93 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.08 |
| Beta | 0.24 |
| Outstanding Shares | 88,200,023 |
Return
| Return on Equity | -11.70% |
|---|---|
| Return on Assets | -11.09% |
| Return on Invested Capital | -22.91% |
Valuation & Multiples
| P/E Ratio | -24.96 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | 6.13 |
| Enterprise Value to Revenue | 952.55 |
| Enterprise Value to EBIT | -24.94 |
| Enterprise Value to Net Income | -50 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$-0.66
Average shareholder expectationRevenue Estimate
$360,805
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.81
Average shareholder expectationRevenue Estimate
$491,235
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3675▼ 7.21% |
|---|---|
| Total Calls | 3,792,819▲ 29.84% |
| Total Puts | 1,393,800▲ 8.55% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 111.76%▲ 7.49% |
|---|---|
| Total Invested | $6.71B▲ 13.14% |
| Investors Holding | 2460% |
ESG Score
No data